Richard E. Gilbert

14.5k total citations · 2 hit papers
210 papers, 10.4k citations indexed

About

Richard E. Gilbert is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Molecular Biology. According to data from OpenAlex, Richard E. Gilbert has authored 210 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Cardiology and Cardiovascular Medicine, 66 papers in Nephrology and 60 papers in Molecular Biology. Recurrent topics in Richard E. Gilbert's work include Chronic Kidney Disease and Diabetes (57 papers), Diabetes Treatment and Management (35 papers) and Cardiovascular Function and Risk Factors (23 papers). Richard E. Gilbert is often cited by papers focused on Chronic Kidney Disease and Diabetes (57 papers), Diabetes Treatment and Management (35 papers) and Cardiovascular Function and Risk Factors (23 papers). Richard E. Gilbert collaborates with scholars based in Australia, Canada and United States. Richard E. Gilbert's co-authors include Darren J. Kelly, Mark E. Cooper, Mark E. Cooper, Alison J. Cox, Henry Krum, Kim A. Connelly, Jennifer L. Wilkinson‐Berka, Kerri Thai, George Jerums and Andrew Advani and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Richard E. Gilbert

207 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?

1999 541 citations Richard E. Gilbert et al. Kidney International profile →
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

2019 386 citations Subodh Verma, C. David Mazer et al. Circulation profile →

Peers

Countries citing papers authored by Richard E. Gilbert

Since Specialization

Citations

This map shows the geographic impact of Richard E. Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Gilbert more than expected).

Fields of papers citing papers by Richard E. Gilbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Gilbert. The network helps show where Richard E. Gilbert may publish in the future.

Co-authorship network of co-authors of Richard E. Gilbert

This figure shows the co-authorship network connecting the top 25 collaborators of Richard E. Gilbert. A scholar is included among the top collaborators of Richard E. Gilbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E. Gilbert. Richard E. Gilbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes 2021 ·Cardiovascular Diabetology ·(unknown), Subodh Verma, C. David Mazer, Hwee Teoh, Adrian Quan, Richard E. Gilbert, Shaun G. Goodman, (unknown), Otávio R. Coelho‐Filho, (unknown), Djeven P. Deva, Vinay Garg, Sumeet Gandhi, Kim A. Connelly, Andrew T. Yan	23
2	Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes 2016 ·PLoS ONE ·Diego Andreazzi Duarte, Alexandros Papadimitriou, Richard E. Gilbert, Kerri Thai, Yanling Zhang, Mariana Aparecida Brunini Rosales, José B. Lopes de Faria, Jacqueline M. Lopes de Faria, (unknown), (unknown)	15
3	Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease 2016 ·PLoS ONE ·Yanling Zhang, Kerri Thai, (unknown), Richard E. Gilbert	58
4	Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes 2013 ·Canadian Medical Association Journal ·Doreen M. Rabi, Raj Padwal, Sheldon W. Tobe, Richard E. Gilbert, Lawrence A. Leiter, Robert R. Quinn, Nadia Khan	14
5	FT011, a New Anti-Fibrotic Drug, Attenuates Fibrosis and Chronic Heart Failure in Experimental Diabetic Cardiomyopathy 2012 ·European Journal of Heart Failure ·Yuan Zhang, Amanda J. Edgley, Alison J. Cox, Andrew K. Powell, Bing H. Wang, Andrew R. Kompa, David Stapleton, Steven C. Zammit, Spencer J. Williams, Henry Krum, Richard E. Gilbert, Darren J. Kelly	41
6	Angiogenic Dysfunction in Bone Marrow-Derived Early Outgrowth Cells from Diabetic Animals Is Attenuated by SIRT1 Activation 2012 ·Stem Cells Translational Medicine ·Darren A. Yuen, Yanling Zhang, Kerri Thai, Christopher M. Spring, Lauren Chan, Xiaoxin Guo, Andrew Advani, Jeremy M. Sivak, Richard E. Gilbert	20
7	Abstract 315: Directly Targeting Myocardial Fibrosis with FT-011 Improves Cardiac Remodeling in Experimental Diabetic Cardiomyopathy 2008 ·Circulation ·Henry Krum, Michael Zhang, Kim A. Connelly, Richard E. Gilbert, Darren J. Kelly	1
8	Abstract 6248: The Direct Renin Inhibitor, Aliskiren, Improves Cardiac Function Via Direct Renin Inhibition And Via Renin Receptor Modulation In A Rodent Model Of Diabetic diastolic heart failure. 2008 ·Circulation ·Kim A. Connelly, Darren J. Kelly, Sandra Kim, Michael Zhang, Kerri Thai, Andrew Advani, Henry Krum, Richard E. Gilbert	3
9	High Glucose-Induced Thioredoxin-Interacting Protein in Renal Proximal Tubule Cells Is Independent of Transforming Growth Factor-β1 2007 ·American Journal Of Pathology ·Weier Qi, Xinming Chen, Richard E. Gilbert, Yuan Zhang, Mark Waltham, Maria Schäche, Darren J. Kelly, Carol A. Pollock	67
10	Abstract 3922: Inhibition of PKC Beta by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy 2006 ·Circulation ·Kim A. Connelly, (unknown), Yuan Zhang, David L. Prior, Henry Krum, Richard E. Gilbert	1
11	Hyperglycemia has a detrimental effect on cardiac remodelling and mortality after myocardial infarction: benefit of statin therapy 2006 ·European Heart Journal ·J. Martín, Kim A. Connelly, (unknown), Andrew R. Kompa, (unknown), Desmond P. Kelly, Richard E. Gilbert, Henry Krum	1
12	Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells 2006 ·Kidney International ·Qi Wu, Xinming Chen, Stephen M. Twigg, Tania Polhill, Richard E. Gilbert, Carol A. Pollock	50
13	Combination therapy with tranilast and angiotensin-converting enzyme inhibition provides additional renoprotection in the remnant kidney model 2006 ·Kidney International ·Darren J. Kelly, Y. Zhang, Alison J. Cox, Richard E. Gilbert	22
14	Heart Failure and Nephropathy 2005 ·Clinical Journal of the American Society of Nephrology ·Richard E. Gilbert, Kim A. Connelly, Darren J. Kelly, Carol A. Pollock, Henry Krum	52
15	An Accelerated Wet Ageing Test on Medium Voltage XLPE Cables 2004 ·QUT ePrints (Queensland University of Technology) ·D. Birtwhistle, (unknown), (unknown), (unknown), Richard E. Gilbert, (unknown), Tapan Kumar Saha	2
16	Mast cell infiltration and chemokine expression in progressive renal disease1 2003 ·Kidney International ·Susan Jones, Darren J. Kelly, Alison J. Cox, Yuan Zhang, Renae M. Gow, Richard E. Gilbert	63
17	Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition 2002 ·Diabetologia ·Robyn G. Langham, Darren J. Kelly, (unknown), Napier M. Thomson, (unknown), Philippe Zaoui, N. Pinel, D Cordonnier, Richard E. Gilbert	184
18	TRANSFORMING GROWTH FACTOR-??1 AND TUMOR GROWTH FACTOR-??-INDUCIBLE GENE-H3 IN NONRENAL TRANSPLANT CYCLOSPORINE NEPHROPATHY 2001 ·Transplantation ·Robyn G. Langham, (unknown), John P. Dowling, Richard E. Gilbert, Napier M. Thomson	36
19	DIABETIC VASCULAR COMPLICATIONS 1997 ·Clinical and Experimental Pharmacology and Physiology ·Mark E. Cooper, Richard E. Gilbert, George Jerums	54
20	Investigation of CO and H 2 adsorption on polycrystalline Pt 1993 ·Journal of Physics Condensed Matter ·Richard E. Gilbert, (unknown), (unknown), Gar B. Hoflund	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact